URGN - CIK 0001668243
UroGen Pharma Ltd. has filed 549 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (182 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Insider sale notice | 144 | 2024-02-01 | - |
| Insider sale notice | 144 | 2024-02-01 | - |
| Major company event | 8-K | 2024-01-17 | 2024-01-16 |
| Major company event | 8-K | 2024-01-02 | 2023-12-28 |
| Passive ownership stake | SC 13G | 2023-12-29 | - |
| SEC correspondence | UPLOAD | 2023-12-05 | - |
| Company correspondence | CORRESP | 2023-11-27 | - |
| SEC correspondence | UPLOAD | 2023-11-16 | - |
| Quarterly report | 10-Q | 2023-11-14 | 2023-09-30 |
| Employee stock plan | S-8 | 2023-11-14 | - |
| Major company event | 8-K | 2023-11-14 | 2023-11-14 |
| EFFECT | - | 2023-09-15 | - |
| Passive ownership stake | SC 13G | 2023-09-15 | - |
| Company correspondence | CORRESP | 2023-09-13 | - |
| SEC correspondence | UPLOAD | 2023-09-12 | - |
| Major company event | 8-K | 2023-09-11 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Insider trade | 4 | 2023-09-08 | 2023-09-07 |
| Securities registration | S-3 | 2023-09-08 | - |
| Insider trade | 4 | 2023-09-05 | 2023-08-31 |
| D | - | 2023-08-14 | - |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Activist ownership stake | SC 13D | 2023-08-04 | - |
| Annual report to shareholders | ARS | 2023-08-01 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-08-01 | - |
| Proxy statement | DEF 14A | 2023-08-01 | 2023-09-07 |
| Insider trade | 4 | 2023-07-28 | 2023-07-26 |
| Insider trade (amended) | 4/A | 2023-07-28 | 2023-07-25 |
| Insider trade | 4 | 2023-07-27 | 2023-07-25 |
| New insider ownership | 3 | 2023-07-27 | 2023-07-25 |
| Major company event | 8-K | 2023-07-27 | 2023-07-26 |
| Major company event | 8-K | 2023-07-25 | 2023-07-25 |
| Passive ownership stake (update) | SC 13G/A | 2023-06-12 | - |
| Insider trade | 4 | 2023-06-09 | 2023-06-08 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Annual report (amended) | 10-K/A | 2023-05-01 | 2022-12-31 |